Wednesday, February 10, 2010, 4:59pm SGT - The Singapore stock market closes in 1 minute.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Immtech Pharmaceuticals, Inc. (IMMP.PK)

On Feb 9: 0.037 USD   0.00 (0.00%)  
 MORE ON IMMP.PK 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 IMMTECH PHARM INC (Other OTC:IMMP.PK) Delayed quote dataEdit
Last Trade:0.037 USD
Trade Time:Feb 9
Change: 0.00 (0.00%)
Prev Close:0.037
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:11.00
Day's Range:N/A - N/A
52wk Range:0.02 - 0.47
Volume:0
Avg Vol (3m):19,214.3
Market Cap:658.82K
P/E (ttm):N/A
EPS (ttm):-0.425
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add IMMP.PK to Portfolio   Download Data

 HEADLINES 
IMMTECH PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Tue, Jul 21)
IMMTECH PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
EDGAR Online (Wed, Jul 15)
IMMTECH PHARMACEUTICALS, INC. Financials
EDGAR Online Financials (Wed, May 27)
IMMTECH PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
EDGAR Online (Fri, May 22)
More Headlines for IMMP.PK...

 ANALYST 
EPS Est (next year) (Mar-08) :N/A
EPS Est (in 2 years) (Mar-09) :N/A
Avg Rec (current)*:5.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Immtech Pharmaceuticals, Inc. focuses on the discovery and development of drugs to treat infectious diseases worldwide. The company involves in drug discovery and development programs for hepatitis C and malaria; and provides aromatic cationic pha...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices